AzTrials
AzTrials

StrokeNCT03501797

Choir Singing in Aphasia Rehabilitation

A study testing Singing-based rehabilitation in people with Stroke and Aphasia, run by University of Helsinki at 2 sites in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the verbal, cognitive, emotional, and neural efficacy of a choir singing intervention in chronic aphasic patients and their caregivers. Using a cross-over RCT design, half of the participants receive a 4-month singing intervention during the first half of the study and half of the participants… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stroke, Aphasia
What is being tested?
Singing-based rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesFinland
Study dates
1 Jan 2018to 15 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

The following inclusion criteria are used in patient recruiment:

  1. age over 18
  2. Finnish-speaking
  3. time since stroke > 6 months
  4. at least minor non-fluent aphasia due to stroke (BDAE Aphasia Severity Rating scale score ≤ 4)
  5. no hearing deficit
  6. no severe cognitive impairment affecting comprehension (the patient is able to understand the purpose of the study and give an informed consent)
  7. no neurological / psychiatric co-morbidity or substance abuse
  8. ability to produce vocal sound (through singing or humming).

Trial locations and contacts

2 sites in 1 country.

Finland2 sites
  • Helsinki University Central Hospital, Department of Neurology, Rehabilitation Unit

    Helsinki

  • Helsinki-Uusimaa Aphasia and Stroke Association

    Helsinki

Other trials in Finland

About this study

Official title: Efficacy of Choir Singing on Verbal, Cognitive, Emotional, and Neural Recovery From Aphasia

This study evaluates the verbal, cognitive, emotional, and neural efficacy of a choir singing intervention in chronic aphasic patients and their caregivers. Using a cross-over RCT design, half of the participants receive a 4-month singing intervention during the first half of the study and half of the participants during the second half of the study.

Read the detailed description

BACKGROUND: Singing is a highly stimulating and versatile activity for the brain, combining vocal-motor, auditory, linguistic, cognitive, emotional, and social brain processes, both in the left and right hemisphere. The capacity to sing is often preserved in aphasia after stroke, and singing-based methods, such as Melodic Intonation Therapy (MIT), can be effective in rehabilitating speech production in aphasics. Also emotionally and socially, singing could provide a powerful alternative channel for aphasic patients to express their emotions and interact with others, but the communal or group-level use of singing in aphasia rehabilitation has not been systematically studied.

AIMS: The purpose of the study is to determine the clinical and neural efficacy of a novel choir singing intervention in subacute/chronic aphasia. Specifically, the targeted outcomes are (i) verbal and vocal-motor skills, (ii) cognitive skills, (iii) emotional functioning and quality of life, (iv) caregiver psychological well-being, and (v) structural and functional neuroplasticity. In addition, the capacity of singing and music learning in aphasia is explored.

METHODS: Subjects are 60 stroke patients with at least minor aphasia (≥ 6 months post-stroke) and their family members (FMs, N = 60) from Helsinki area recruited to a cross-over RCT study. Participants are randomized to two groups [N = 60 in both (30 patients, 30 FMs)], which receive a 16-week choir intervention either during the first (AB group) or second (BA group) half of the follow-up. The intervention is a combination of group training, which utilizes a novel combination of traditional senior choir singing and MIT-like speech training protocols, and home training in which the choir material is trained with a tablet computer. All patients are evaluated at baseline, 5-month, and 9-month stages with language, cognitive, and auditory-music tests and questionnaires. Half of the patients (N = 30) also undergo electroencephalography (EEG) and structural and functional magnetic resonance imaging (s/fMRI). FMs are evaluated with questionnaires.

Conditions
Stroke, Aphasia
Being tested
Singing-based rehabilitation, Standard care
Medical subject headings
Stroke, Aphasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Singing-based rehabilitationBehavioural

    The singing-based rehabilitation is a combination of group-training (16 weeks, 1 x week, 90 min), which utilizes a novel combination of traditional senior choir singing and singing-based speech training protocols, and home training (16 weeks, ≥ 3 x week, ≥ 30 min) in which the choir material is trained with a tablet computer.

  • Standard careOther

    Standard care comprises all rehabilitation and care services (e.g. speech therapy, physical and occupational therapy, neuropsychological rehabilitation) received by the patients in the Finnish health care system

Study groups in NCT03501797
Study groupRoleWhat they receive
Early singing intervention (AB)ExperimentalParticipants receive a 16 weeks of singing-based rehabilitation and standard care (SC) followed by 16 weeks of SC only.
Receives: Behavioral: Singing-based rehabilitation; Other: Standard care
Late singing intervention (BA)ExperimentalParticipants receive a 16 weeks of SC only followed by 16 weeks of singing intervention and SC.
Receives: Behavioral: Singing-based rehabilitation; Other: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Communication ability

    Total score of the Communication Action Log (CAL) questionnaire (range 0-180, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  2. Spontaneous speech production

    Spontaneous Speech subscale score of the Western Aphasia Battery (WAB) (range 0-20, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  3. Connected speech informativeness

    Percentage of correct information units (CIUs) produced in a picture description task

    Measured: Change from baseline at 5 months and 9 months

  4. Repetition of words and sentences

    Repetition subscale score of the Western Aphasia Battery (WAB) (range 0-100, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  5. Verbal agility

    Verbal Agility subtest score of the Boston Diagnostic Aphasia Examinaton (BDAE) (range 0-14, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  6. Naming and word finding

    Naming and Word Finding subscale score of the Western Aphasia Battery (WAB) (range 0-100, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  7. Verbal comprehension

    Sequential Commands subtest score of the Western Aphasia Battery (WAB) (range 0-80, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

Secondary outcomes (20)
  1. Executive function (correct responses)

    Simon Task: score (range 0-100, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  2. Executive function (reaction times)

    Simon Task: reaction time mean (ms)

    Measured: Change from baseline at 5 months and 9 months

  3. Attention (correct responses)

    Flexible Attention Test (FAT): score (range 0-48, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  4. Attention (reaction times)

    Flexible Attention Test (FAT): reaction time mean (ms)

    Measured: Change from baseline at 5 months and 9 months

  5. Working memory

    Word Span subtest score of the Kielelliset Arviointitehtävät (KAT) (range 0-30, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  6. Verbal memory

    Logical Memory subtest score of the Wechsler Memory Scale III (WMS-III) (range 0-80, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  7. Verbal learning

    Word Lists subtest score of the Wechsler Memory Scale III (WMS-III) (range 0-84, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  8. Singing ability

    Acoustic features (e.g., pitch, rhythm, intensity) analyzed from recorded production of familiar and novel songs using acoustic analysis software

    Measured: Change from baseline at 5 months and 9 months

  9. Music perception

    Montreal Battery of Evaluation of Amusia (MBEA) score (range 0-30, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  10. Functional stroke recovery

    Total score of the Stroke Impact Scale (SIS) questionnaire (range 0-900, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  11. Depression

    Total score of the Center for Epidemiological Studies Depression Scale (CES-D) questionnaire (range 0-60, lower score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  12. Mood

    Total score of the Visual Analog Mood Scales (VAMS) questionnaire (range 0-800, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  13. Social interaction

    Total score of the Social Provision Scale (SPS) questionnaire (range 24-96, higher score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  14. Caregiver burden

    Total score of the Zarit Burden Interview (ZBI-22) questionnaire (range 0-88, lower score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  15. Psychological stress of the caregiver

    Total score of the General Health Questionnaire (GHQ-12) (range 0-36, lower score indicates better outcome)

    Measured: Change from baseline at 5 months and 9 months

  16. Electroencephalography (EEG)

    Amplitude and latency of event-related potentials (ERPs) associated with learning and memory in two auditory tasks

    Measured: Change from baseline at 5 months and 9 months

  17. Structural magnetic resonance imaging (sMRI): MPRAGE sequence

    Grey matter volume in frontotemporal, frontoparietal, and limbic brain regions

    Measured: Change from baseline at 5 months and 9 months

  18. Structural magnetic resonance imaging (sMRI): DTI sequence

    Structural connectivity of intra- and interhemispheric white matter tracts

    Measured: Change from baseline at 5 months and 9 months

  19. Functional magnetic resonance imaging (fMRI): resting-state

    resting-state fMRI sequence: functional connectivity of frontotemporal, frontoparietal, and limbic brain networks

    Measured: Change from baseline at 5 months and 9 months

  20. Functional magnetic resonance imaging (fMRI): singing-related activity

    task-based fMRI sequence: frontotemporal, frontoparietal, and limbic activation patterns associated with the perception, vocal repetition, and recall of novel songs

    Measured: Change from baseline at 5 months and 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2018
  2. Study start1 Jan 2018
  3. Primary completion31 Jan 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03501797
Sponsor's protocol ID
306625
Status last verified
Aug 2022
First submitted
16 Feb 2018
Last updated
18 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Martinez-Molina N, Pitkaniemi A, Siponkoski ST, Moisseinen N, Kuusela L, Laitinen S, Sarkamo ER, Pekkola J, Melkas S, Schlaug G, Kleber B, Sihvonen AJ, Sarkamo T. Functional neuroplasticity in chronic post-stroke aphasia following a singing intervention in a cross-over randomised trial. Sci Rep. 2025 Jul 29;15(1):27639. doi: 10.1038/s41598-025-11288-0.

    PubMed 40738917
  • Siponkoski ST, Pitkaniemi A, Laitinen S, Sarkamo ER, Pentikainen E, Eloranta H, Tuomiranta L, Melkas S, Schlaug G, Sihvonen AJ, Sarkamo T. Efficacy of a multicomponent singing intervention on communication and psychosocial functioning in chronic aphasia: a randomized controlled crossover trial. Brain Commun. 2022 Dec 27;5(1):fcac337. doi: 10.1093/braincomms/fcac337. eCollection 2023.

    PubMed 36687394

Questions about this trial

What is this clinical trial studying?

A study testing Singing-based rehabilitation in people with Stroke and Aphasia, run by University of Helsinki at 2 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Communication ability (time frame: Change from baseline at 5 months and 9 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03501797, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in